Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders
- PMID: 20306269
- PMCID: PMC2866090
- DOI: 10.1007/s00401-010-0664-3
Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders
Abstract
A sensitive immunohistochemical method for phosphorylated alpha-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson's disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer's disease with Lewy bodies (ADLB) and 17 with Alzheimer's disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated alpha-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.
Figures





Similar articles
-
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. doi: 10.5692/clinicalneurol.48.11. Rinsho Shinkeigaku. 2008. PMID: 18386627 Review. Japanese.
-
Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders.Mov Disord. 2014 Jul;29(8):1010-8. doi: 10.1002/mds.25776. Epub 2014 Jan 2. Mov Disord. 2014. PMID: 24395122
-
Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure.Clin Auton Res. 2018 Apr;28(2):223-230. doi: 10.1007/s10286-017-0495-6. Epub 2018 Feb 2. Clin Auton Res. 2018. PMID: 29396794
-
Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.Brain. 2008 Mar;131(Pt 3):642-50. doi: 10.1093/brain/awm302. Epub 2007 Dec 13. Brain. 2008. PMID: 18079166
-
A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5. Biochim Biophys Acta. 2009. PMID: 18718530 Review.
Cited by
-
Large-fiber neuropathy in Parkinson's disease: a narrative review.Neurol Res Pract. 2024 Oct 28;6(1):51. doi: 10.1186/s42466-024-00354-z. Neurol Res Pract. 2024. PMID: 39465424 Free PMC article. Review.
-
Parkinson's Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?Front Neurosci. 2021 Feb 25;14:580311. doi: 10.3389/fnins.2020.580311. eCollection 2020. Front Neurosci. 2021. PMID: 33716638 Free PMC article. Review.
-
Structural alterations of the intestinal epithelial barrier in Parkinson's disease.Acta Neuropathol Commun. 2015 Mar 10;3:12. doi: 10.1186/s40478-015-0196-0. Acta Neuropathol Commun. 2015. PMID: 25775153 Free PMC article.
-
Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans.Mov Disord. 2021 Sep;36(9):2094-2103. doi: 10.1002/mds.28636. Epub 2021 May 3. Mov Disord. 2021. PMID: 33942370 Free PMC article.
-
Diagnostic accuracy and predictors of alpha-synuclein accumulation in the gastrointestinal tract of Parkinson's disease.NPJ Parkinsons Dis. 2024 Aug 15;10(1):155. doi: 10.1038/s41531-024-00766-3. NPJ Parkinsons Dis. 2024. PMID: 39147801 Free PMC article.
References
-
- Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol Aging. 1997;18:S1–S2. - PubMed
-
- Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57:456–462. - PubMed
-
- Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord. 2007 - PubMed
-
- Adler CH. Nonmotor complications in Parkinson’s disease. Mov Disord. 2005;20 Suppl 11:S23–S29. - PubMed
-
- Adler CH, Hentz JG, Joyce JN, Beach T, Caviness JN. Motor impairment in normal aging, clinically possible Parkinson’s disease, and clinically probable Parkinson’s disease: longitudinal evaluation of a cohort of prospective brain donors. Parkinsonism Relat Disord. 2002;9:103–110. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical